Zydus Lifesciences Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZYDUSLIFE.BO | 0QFP.IL | ERIS.BO | MEGA.BK | 0MTD.IL | FDC.BO | |
|---|---|---|---|---|---|---|
| Market cap | 1.19T | 4.46T | 170.64B | 30.95B | 179.30B | 63.76B |
| P/E (TTM) | 28.6 | 18.8 | 23.9 | 14.2 | 50.9 | 20.4 |
| Forward P/E | 24.0 | — | 22.0 | 12.4 | — | 30.1 |
| Price/book | 4.3 | 2.1 | 4.1 | 3.0 | 5.2 | 2.4 |
| Dividend yield | 0.08% | 7.74% | 1.18% | 4.86% | — | 2.56% |
| 1-year change | +27.10% | 0.00% | −23.16% | +20.69% | +46.92% | −7.27% |
| Today | +0.54% | +156.25% | +1.03% | +1.43% | +2.72% | +0.13% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All ZYDUSLIFE.BO news ›Q2 Results 04th Nov Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah Share to announce Q2 results, Bajaj Finserv, SBI, NSE, Lupin shares in focus
Follow our stock market live updates here | Stay tuned to businessline for more. GAINERS: SBI, Emcure Pharma, Awfis Space Sensex gained 214.75 pts or 0.28% to 77,132.60 at 9.16 am after opening at 76,853.11 from 76,917.85 previous close.…
India's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Consolidated net profit fell to 9.26 billion rupees ($97.77 million) for the July-September quarter from 12.61 billion rupees a year earlier. • Total revenue rose 29.2% year-on-year to 79.10 billion but expenses grew at a faster pace of…
Zydus Lifesciences net profit down 26.6 pc to Rs 925.5 cr in Q2
New Delhi, Nov 4 (PTI) Zydus Lifesciences on Wednesday posted a 26.6 per cent decline in consolidated net profit to Rs 925.5 crore in the September quarter weighed down by an increase in expenses. The company had posted a net profit of Rs…
Zydus Lifesciences Q2 FY27 Results: Key Figures Disclosed
Kalkine India Zydus Lifesciences (NSE:ZYDUSLIFE): What Did Q2 FY27 Results Reveal? Source: Krish Capital Pty Ltd Zydus Lifesciences (NSE:ZYDUSLIFE) disclosed its unaudited standalone and consolidated financial results for the quarter and…
Top stocks to buy in F&O segment: CDSL, Zydus Lifesciences, Sun Pharma by Jay Thakkar for near-term | Check targets
Indian equity benchmarks ended largely flat on Tuesday, 27 October as elevated crude oil prices kept investor sentiment cautious, with market participants awaiting the US Federal Reserve’s policy decision later this week. The Nifty 50…
Trade Spotlight: How should you trade BSE, Mankind Pharma, Bajaj Finserv, Bharti Airtel, Zydus Lifesciences, and others on October 27?
The benchmark indices rebounded on October 26, with the Nifty 50 rising 0.68 percent amid positive market breadth. On the NSE, 1,867 shares advanced against 1,407 declining shares. However, the market is expected to remain cautious amid…
Zydus Lifesciences To Invest Over ₹166 Crore In Sri Lanka Manufacturing Facility
Zydus Lifesciences, through its joint venture Zydus Sunshine Lifesciences, will invest more than ₹166 crore to establish a pharmaceutical manufacturing facility in Sri Lanka. Commercial operations are expected to begin in 2028. The joint…
Zydus Lifesciences receives ESG rating of 71 for 2026
Zydus Lifesciences Limited has been assigned an overall Environmental, Social, and Governance (ESG) rating of 71 for the financial year 2026. This rating places the company in the 'leader' category, as per the assessment conducted by NSE…
Zydus Lifesciences Secures USFDA Final Approval for Menopause Treatment Patch with USD 45.7 Million US Sales
New Delhi: Zydus Lifesciences Limited (Zydus) has announced that the United States Food and Drug Administration (USFDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Estradiol and Levonorgestrel Transdermal…
PNB, Indian Hotels, Zydus Lifesciences: Top stocks to trade — Check key levels, targets & stop loss
Master Capital Services said that Indian Hotels has broken out of a prolonged consolidation phase above resistance, signalling renewed buying interest and strengthening its bullish outlook.
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- businessupturn.com4
- sahi.com4
- medicaldialogues.in3
- freepressjournal.in2
- kalkine.co.in2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 30 articles, not a forecast.